Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kyverna Therapeutics, Inc. - Common Stock (NQ: KYTX )

3.290 -0.040 (-1.20%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 177,691
Open 3.420
Bid (Size) 3.280 (2)
Ask (Size) 3.550 (3)
Prev. Close 3.330
Today's Range 3.270 - 3.469
52wk Range 3.270 - 35.06
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kyverna, Sun Communities, Cassava, and Marqeta and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
KYTX ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against Kyverna Therapeutics, Inc.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market

Performance

YTD
-16.07%
-16.07%
1 Month
-22.41%
-22.41%
3 Month
-40.51%
-40.51%
6 Month
-68.67%
-68.67%
1 Year
-89.03%
-89.03%

More News

Read More
KYTX ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against Kyverna Therapeutics, Inc.
Via TheNewswire.com
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
ROSEN, LEADING INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX
From The Rosen Law Firm PA
Via GlobeNewswire
KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Kyverna Therapeutics, Inc. (KYTX) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds KYTX Investors of Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Kyverna Therapeutics, Inc. (KYTX) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds KYTX Investors of Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Kessler Topaz Meltzer & Check, LLP Notifies Kyverna Therapeutics, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Kessler Topaz Meltzer & Check, LLP Notifies Kyverna Therapeutics, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Kirby McInerney LLP Urges Investors in Kyverna Therapeutics, Inc. to Inquire About Their Rights in Class Action Lawsuit
From Kirby McInerney LLP
Via Business Wire
KYTX Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Kyverna Therapeutics, Inc. Investors to Contact the Firm About Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
KYTX Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Kyverna Therapeutics, Inc. Investors to Contact the Firm About Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kyverna, Sun Communities, Cassava, and MGPI and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
Kessler Topaz Meltzer & Check, LLP Reminds KYTX Investors of February 7, 2025 Deadline in Securities Fraud Class Action and Urges Investors With Losses to Contact the Firm
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX
From The Rosen Law Firm PA
Via GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Encourages Kyverna Therapeutics, Inc. Investors With Losses to Contact the Firm
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Faruqi & Faruqi Reminds Kyverna Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 – KYTX
From Faruqi & Faruqi LLP
Via GlobeNewswire
Kessler Topaz Meltzer & Check, LLP - Class Action Announcement for Kyverna Therapeutics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Kyverna Therapeutics, Inc.
From Kessler Topaz Meltzer & Check LLP
Via GlobeNewswire
Investor Reminder (KYTX): Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of February 7, 2025 Deadline
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
KYVERNA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.